Interdialytic ambulatory blood pressure in patients with intradialytic hypertension

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 1, 2012, Pages 15-23

  Van Buren, Peter N ^a   Toto, Robert ^a   Inrig, Jula K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ambulatory blood pressure; endothelial cell dysfunction; hemodialysis; hypertension; intradialytic hypertension

Indexed keywords

CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; LISINOPRIL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINAPRIL;

ARTERIAL STIFFNESS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); ENDOTHELIAL DYSFUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; INTRADIALYTIC HYPERTENSION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARBAZOLES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PROPANOLAMINES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 83055170822     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834db3e4     Document Type: Review

References (36)

1. United States Renal Data System. USRDS 2010 Annual Data Report: Atlas of chronic kidney disease and end stage renal disease in the United States. Bethesda, Maryland: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
2. Foley RN, Parfrey PS, Harnett JD, et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379-1385. (Pubitemid 26166411)
3. Agarwal R, Nissenson A, Battle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 2003; 115:291-297. (Pubitemid 37088191)
4. Lewington S, Clarke R, Qizilbash N, et al. Age specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913. (Pubitemid 35472129)
5. Li Z, Lacson E, Lowrie E, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48:606-615. (Pubitemid 44425376)
6. Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value then hemodialysis unit recordings. Clin J Am Soc Nephrol 2007; 2:1228-1234.
7. Inrig J, Oddone E, Hasselblad V, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 2007; 71:454-461.
8. Inrig J, Patel N, Toto R, Szczech LA. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 2009; 54:881-890.
9. National Heart, Lung, and Blood Institute (NHLBI), The University of Texas Southwestern Medical Center at Dallas. Mechanism and treatment of intradialytic hypertension [online NCT 00827775]. Bethesda, Maryland: National Library of Medicine; 2000. http://clinicaltrials.gov/ct2/show/NCT00827775 [accessed 27 October 2010].
10. Amerling R, Dubrow A, Levin N, et al. Complications during hemodialysis. Stamford: Appleton and Lange; 1995.
11. Raj D, Vincent B, Simpson K, et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 2002; 61:697-704. (Pubitemid 34102613)
12. Chou K, Lee P, Chen C, et al. Physiologic changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 2006; 69:1833-1838. (Pubitemid 43739212)
13. El Shafey E, El Nagar G, Selim M, et al. Is there a role for endothelin-1 in the hemodynamic changes during dialysis? Clin Exp Nephrol 2008; 12:370-375.
14. Agarwal R, Light R. Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant 2010; 25:3355-3361.
15. Van Buren P, Kim C, Toto R, Inrig J. Prevalence of recurrent intradialytic hypertension [abstract]. Am J Kidney Dis 2011; 57:B100.
16. Inrig JK. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis 2010; 55:580-589.
17. Chazot C, Guillaume J. Intradialytic hypertension: it is time to act. Nephron Clin Pract 2010; 115:182-188.
18. Cirit M, Akcicek F, Terzioglu E, et al. Paradoxical rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 1995; 10:1417-1420.
19. Gunal A, Karaca I, Celiker H, et al. Paradoxical rise in blood pressure during ultrafiltration is caused by increased cardiac output. J Nephrol 2002; 15:42-47. (Pubitemid 34245348)
20. Inrig J, Van Buren P, Kim C, et al. Intradialytic hypertension and its association with endothelial cell dysfunction. Clin J Am Soc Nephrol 2011; 6:2016-2024.
21. Fourtounas C. Malignant intradialytic hypertension: a severe form of intradialytic hypertension. Am J Kidney Dis 2010; 56:418.
22. Oberleithner H, Riethmuller C, Schillers H, et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA 2007; 104:16281-16286. (Pubitemid 350099397)
23. University of Texas Southwestern Medical Center. Mechanisms and treatment of intradialytic hypertension-sodium (MATCH-Sodium) [NLM identifier NCT 01371890]. ClinicalTrials.gov [Internet]. Bethesda, Maryland: National Library of Medicine; 2011. http://www.clinicaltrials.gov/ct2/show/NCT01371890 [accessed 10 June 2011]
24. Inrig JK, Patel UD, Gillespie BS, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 2007; 50:108-118; 18 e1-e4.
25. Van Buren P, Toto R, Inrig J. Effect of interdialytic weight gain on intradialytic hypertension [abstract]. J Invest Med 2011; 59:372-544.
26. Agarwal R, Peixoto A, Santos S, Zoccalu C. Pre and postdialysis blood pressure are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1:389-396.
27. Agarwal R, Metiku T, Tegegne G, et al. Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol 2008; 3:1364-1372.
28. Van Buren P, Kim C, Toto R, Inrig J. Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2011; 6:1684-1691.
29. Kelley K, Light R, Agarwal R. Trended cosinor change model for analyzing hemodynamic rhythm pattern in hemodialysis patients. Hypertension 2007; 50:143-150. (Pubitemid 46986023)
30. Agarwal R, Light RP. Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol 2008; 294:F303-F308. (Pubitemid 351199394)
31. Agarwal R. Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension 2009; 54:241-247.
32. Heerspink H, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomized controlled trials. Lancet 2009; 373:1009-1015.
33. Agarwal R, Sinha A. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension 2009; 53:860-866.
34. Inrig J. Antihypertensive agents in hemodialysis patients: a current perspective. Semin Dial 2010; 23:290-297.
35. Inrig J, Van Buren P, Kim C, Toto R. Carvedilol for the treatment of intradialytic hypertension: the Mechanisms and Treatment of Intradialtyic Hypertension (MATCH) study [abstract]. J Clin Hypertens 2011; 13:A4-A5.
36. Cannella G, Paoletti E, Ravera G, et al. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int 2000; 58:260-268. (Pubitemid 30429871)